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Cartilage tissue engineering using a novel cell-derived 
extracellular matrix (ECM) scaffold in vitro and in vivo
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1Orthopaedic Surgery, Ajou university, Suwon, Korea, 2Physiology,
Inha University College of Medicine, incheon, Korea, 3Cell Therapy 
Center, Ajou University School of Medicine, Suwon, Korea, 
4Department Of Orthopaedic Surgery, NanJing First Hospital, 
Jiangsu, China, 5Orthopaedic Surgery, Ajou University School of 
Medicine, Suwon, Korea
Purpose: In this study a cartilaginous tissue was fabricated by culture 
of rabbit articular chondrocytes seeded on a novel porous cell-
derived ECM scaffold in vitro that was made from cultured porcine 
chondrocytes. Based on the in vitro results, the chondrocytes seeded 
ECM scaffold was implanted into rabbit osteochondral defects on 
the patellar groove to evaluate its feasibility as a reconstructive 
construct for cartilage restoration. 
Methods and Materials: The chemical composition of the ECM 
scaffold was examined by HPLC following 2-D analysis and FT-IR 
BTTBZ"DBSUJMBHJOPVTUJTTVFXBT¾STUGBCSJDBUFEJOWJUSPCZDVMUVSJOH
rabbit articular chondrocytes on the cell-derived ECM scaffold for 4 
weeks. The neocartilages were analyzed by histological and chemical 
assays for GAG, collagen and DNA contents. In in vivo study, the 
cultured neocartilage tissue in vitro was implanted into the rabbit 
osteochondral defects on the patellar groove (5mm in diameter), 
and the repair of the cartilage was evaluated by gross observation, 
histological assays and ICRS score at 1 and 3 months post-surgery. 
Results: The in vitro cultured tissues were observed as a white and 
smooth cartilage-like tissue by gross and histological staining such 
as Safranin O stain. In the rabbit study, the cartilage defects were 
¾MMFEXJUIIZBMJOFMJLFDBSUJMBHFUJTTVFTIPXJOHNBUVSFNBUSJYBOE
columnar organization of chondrocytes in experimental group at 3 
NPOUITQPTUTVSHFSZ5IF*$34IJTUPMPHJDBMTDPSFTXFSFTJHOJ¾DBOUMZ
increased over time. 
Conclusions: In conclusion, our cell-derived ECM scaffold could be a 
promising supporting material for cartilage tissue engineering. 
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In situ Tissue Engineering - cell-free regeneration of cartilage 
defects
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C. Erggelet4;
1R&D, TransTissueTechnologies GmbH, Berlin, Germany, 2Tissue
Engineering Laboratory, Charité-University Medicine Berlin, Berlin, 
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4Orthopedic Surgery, Arthose Clinic Zurich, Zurich, Switzerland
Purpose: Currently applied cartilage tissue engineering grafts are 
based on the implantation of chondrocytes. The objective of this 
study was the development of a cell-free cartilage tissue engineering 
graft that allows the in situ recruitment of mesenchymal stem 
cells (MSC) by chemoattractants and subsequent guidance of the 
progenitors towards formation of cartilage repair tissue. 
Methods and Materials: Chemotactic activity of chemokines, 
TZOPWJBM¿VJE	4'
BOEIVNBOTFSVNXBTUFTUFEJOXFMMDIFNPUBYJT
assays. Chondrogenic differentiation was assessed by histological 
BOBMZTJTBOEHFOFFYQSFTTJPOQSP¾MJOHBGUFS TUJNVMBUJOH.4$XJUI
hyaluronan and SF in high-density cultures. Chemoattractants and 
chondroinductors were combined with poly-glycolic acid (PGA) 
scaffolds and were implanted into full-thickness articular cartilage 
defects of the sheep pre-treated with microfracture. Defects treated 
with microfracture served as controls. 
Results: Distinct chemokines, like SDF1 and IL8, recruited MSC, 
and SF as well as human serum were potent chemoattractants. 
Chondrogenic differentiation of MSC upon stimulation with SF or 
hyaluronan was shown by the formation of a proteoglycan-rich tissue 
in vitro and the induction of typical chondrogenic marker genes like 
type II collagen and aggrecan. 3 months after implantation of the 
cell-free graft, histological analysis documented the formation of a 
cartilaginous repair tissue. Controls treated with microfracture, only, 
showed no formation of a repair tissue. 
Conclusions: )FSFXFSFQPSU UIFEFWFMPQNFOUPG UIF¾STUDFMMGSFF
in situ cartilage tissue engineering graft utilizing the migration and 
differentiation potential of mesenchymal progenitors. The cell-free 
cartilage graft is well suited for the treatment of cartilage defect after 
microfracture. 
